Adaptimmune Therapeutics PLC Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptimmune Therapeutics PLC for September 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Sonsini Peter W. | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Sonsini Peter W. | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | KERINS PATRICK J | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BASKETT FOREST | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BASKETT FOREST | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BARRIS PETER J | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | BARRETT M JAMES | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |